Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 3
2013 2
2014 2
2015 3
2016 3
2017 3
2018 2
2019 2
2020 2
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Rabbit model with vocal fold hyperadduction.
Takemoto N, Sanuki T, Esaki S, Iwasaki S. Takemoto N, et al. Among authors: esaki s. Auris Nasus Larynx. 2022 Oct;49(5):810-815. doi: 10.1016/j.anl.2022.01.008. Epub 2022 Jan 31. Auris Nasus Larynx. 2022. PMID: 35093243
Use of Actigraphy for a Rat Behavioural Sleep Study.
Esaki S, Nakayama M, Arima S, Sato S. Esaki S, et al. Clocks Sleep. 2021 Aug 2;3(3):409-414. doi: 10.3390/clockssleep3030028. Clocks Sleep. 2021. PMID: 34449568 Free PMC article.
An improved system for grading and treating tinnitus.
Takahashi M, Kabaya K, Sekiya K, Matsuda F, Sekiya Y, Esaki S, Sato Y, Inagaki A, Murakami S. Takahashi M, et al. Among authors: esaki s. Auris Nasus Larynx. 2018 Aug;45(4):711-717. doi: 10.1016/j.anl.2017.11.012. Epub 2017 Nov 27. Auris Nasus Larynx. 2018. PMID: 29191364
Oncolytic activity of HF10 in head and neck squamous cell carcinomas.
Esaki S, Goshima F, Ozaki H, Takano G, Hatano Y, Kawakita D, Ijichi K, Watanabe T, Sato Y, Murata T, Iwata H, Shibamoto Y, Murakami S, Nishiyama Y, Kimura H. Esaki S, et al. Cancer Gene Ther. 2020 Aug;27(7-8):585-598. doi: 10.1038/s41417-019-0129-3. Epub 2019 Sep 3. Cancer Gene Ther. 2020. PMID: 31477804 Free PMC article.
Impact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors.
Matoba T, Minohara K, Kawakita D, Takano G, Oguri K, Murashima A, Nakai K, Iwaki S, Tsuge H, Tanaka N, Imaizumi S, Hojo W, Matsumura A, Tsukamoto K, Esaki S, Iwasaki S. Matoba T, et al. Among authors: esaki s. Sci Rep. 2022 Aug 22;12(1):14319. doi: 10.1038/s41598-022-18611-z. Sci Rep. 2022. PMID: 35996017 Free PMC article.
Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab.
Minohara K, Matoba T, Kawakita D, Takano G, Oguri K, Murashima A, Nakai K, Iwaki S, Hojo W, Matsumura A, Ozaki S, Ozawa T, Harata I, Tanaka N, Maseki S, Tsuge H, Imaizumi S, Mitsuya S, Moribe K, Esaki S, Iwasaki S. Minohara K, et al. Among authors: esaki s. Sci Rep. 2021 Aug 20;11(1):16992. doi: 10.1038/s41598-021-96538-7. Sci Rep. 2021. PMID: 34417539 Free PMC article.
Oncolytic activity of naturally attenuated herpes-simplex virus HF10 against an immunocompetent model of oral carcinoma.
Takano G, Esaki S, Goshima F, Enomoto A, Hatano Y, Ozaki H, Watanabe T, Sato Y, Kawakita D, Murakami S, Murata T, Nishiyama Y, Iwasaki S, Kimura H. Takano G, et al. Among authors: esaki s. Mol Ther Oncolytics. 2020 Dec 19;20:220-227. doi: 10.1016/j.omto.2020.12.007. eCollection 2021 Mar 26. Mol Ther Oncolytics. 2020. PMID: 33665360 Free PMC article.
23 results